Cournonterral, France

Patrick Gautier



Average Co-Inventor Count = 3.8

ph-index = 5

Forward Citations = 71(Granted Patents)


Location History:

  • Courmonterral, FR (1985)
  • Cournonterral, FR (1982 - 2005)
  • Antony, FR (2010)

Company Filing History:


Years Active: 1982-2010

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Patrick Gautier

Introduction

Patrick Gautier is a notable inventor based in Cournonterral, France. He has made significant contributions to the field of pharmaceuticals, holding a total of 11 patents. His work focuses on developing novel compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents are the indolizine derivatives, which include a method for preparing these compounds and therapeutic compositions that incorporate them. This invention is directed towards compounds of formula (I), described as novel indolizine derivatives, along with a method for their preparation and pharmaceutical compositions. Another significant patent involves aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives. This invention relates to the preparation of these derivatives, the pharmaceutical compositions that contain them, and their use in treating cardiovascular system pathologies.

Career Highlights

Throughout his career, Patrick Gautier has worked with prominent companies in the pharmaceutical industry, including Sanofi and Sanofi-Aventis. His experience in these organizations has allowed him to contribute to various innovative projects and advancements in drug development.

Collaborations

Patrick has collaborated with several professionals in his field, including Dino Nisato and Claude Bernhart. These collaborations have further enriched his work and have led to the development of impactful pharmaceutical solutions.

Conclusion

Patrick Gautier's innovative work and numerous patents highlight his significant role in advancing pharmaceutical research. His contributions continue to influence the development of new therapeutic options for various medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…